Firefly Neuroscience AIFF
NASDAQ AIFF
$1.62 -0.07 (-4.14%)
At close: Sep 29, 2026 · 4:00 PM EDT

Firefly Neuroscience (AIFF) EBITDA Margin (2010 - 2026)

Updated

Firefly Neuroscience (AIFF) posted EBITDA Margin of -374.90% for Q2 2026, up 157.20 percentage points from -532.11% a year earlier and up 30.25 percentage points from the prior quarter.

Analysis

Firefly Neuroscience (AIFF) EBITDA Margin (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EBITDA Margin at Firefly Neuroscience was -496.89%, up 2138.16 percentage points year-over-year; for FY2025, it came in at -760.42%, up 8486.80 percentage points from FY2024.

  • Annual EBITDA Margin shows a five-year change of -763.47 percentage points (FY2020 to FY2025).
  • In prior years, Firefly Neuroscience's EBITDA Margin was -9247.22% in FY2024 (-8629.15 pp), -618.07% in FY2023 (-570.91 pp), -47.16% in FY2022 (-31.26 pp) and -15.90% in FY2021 (-18.95 pp).
  • The Q2 2026 figure stands as the highest quarterly EBITDA Margin since Q2 2023.
  • On a year-over-year basis, EBITDA Margin has increased in each of the last seven quarters, with an average year-over-year change of +3909.67 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for EBITDA Margin in the past five years was Q3 2025, with a gain of 12251.62 percentage points; the weakest was Q2 2024, with a drop of 12577.01 percentage points.
  • According to Business Quant data, EBITDA Margin for the three prior quarters was -405.15% (Q1 2026), -594.42% (Q4 2025) and -669.59% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn 24.20%
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn 21.86%
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn 28.51%
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn 41.08%
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn 25.55%
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn 29.67%
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn 28.17%
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn 24.62%
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn 31.93%
10 Firefly Neuroscience 34.78 Mn 15.35 Mn 253,000.00 -374.90%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -374.90%
Mar 31, 2026 -405.15%
Dec 31, 2025 -594.42%
Sep 30, 2025 -669.59%
Jun 30, 2025 -532.11%
Mar 31, 2025 -4,758.14%
Dec 31, 2024 -6,371.70%
Sep 30, 2024 -12,921.21%
Jun 30, 2024 -12,550.00%
Mar 31, 2024 -9,091.67%
Dec 31, 2023 -9,113.01%
Sep 30, 2023 -2,566.77%
Jun 30, 2023 27.01%
Mar 31, 2023 -41.69%
Dec 31, 2022 -48.63%
Sep 30, 2022 -46.68%
Jun 30, 2022 -41.18%
Mar 31, 2022 -54.07%
Dec 31, 2021 -106.13%
Sep 30, 2021 -0.68%
API Access

Firefly Neuroscience EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=AIFF&period=max&api_key=YOUR_API_KEY